SANO trial: innovations, risks, and unanswered questions

Sheraz R. Markar; Mark Van Berge Henegouwen; Christiane Bruns; Lorenzo Ferri; Richard van Hillegersberg; Wayne Hofstetter; Magnus Nilsson

doi:10.1016/S1470-2045(25)00237-2

SANO trial: innovations, risks, and unanswered questions

Sheraz R. Markar, Mark Van Berge Henegouwen, Christiane Bruns, Lorenzo Ferri, Richard van Hillegersberg, Wayne Hofstetter, Magnus Nilsson

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	e338
Journal	The Lancet Oncology
Volume	26
Issue number	7
DOIs	https://doi.org/10.1016/S1470-2045(25)00237-2
Publication status	Published - Jul 2025

Access to Document

10.1016/S1470-2045(25)00237-2

Cite this

@article{5222884985044c5c8a901286c07c19b7,

title = "SANO trial: innovations, risks, and unanswered questions",

author = "Markar, {Sheraz R.} and {Van Berge Henegouwen}, Mark and Christiane Bruns and Lorenzo Ferri and {van Hillegersberg}, Richard and Wayne Hofstetter and Magnus Nilsson",

year = "2025",

month = jul,

doi = "10.1016/S1470-2045(25)00237-2",

language = "English",

volume = "26",

pages = "e338",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Limited",

number = "7",

}

TY - JOUR

T1 - SANO trial

T2 - innovations, risks, and unanswered questions

AU - Markar, Sheraz R.

AU - Van Berge Henegouwen, Mark

AU - Bruns, Christiane

AU - Ferri, Lorenzo

AU - van Hillegersberg, Richard

AU - Hofstetter, Wayne

AU - Nilsson, Magnus

PY - 2025/7

Y1 - 2025/7

UR - http://www.scopus.com/inward/record.url?scp=105009138077&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(25)00237-2

DO - 10.1016/S1470-2045(25)00237-2

M3 - Letter

AN - SCOPUS:105009138077

SN - 1470-2045

VL - 26

SP - e338

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 7

ER -

SANO trial: innovations, risks, and unanswered questions

Access to Document

Other files and links

Cite this